Mace Rothenberg, Director at Tango Therapeutics, Inc. (TNGX), bought 20,000 shares at $3.78 ($74K) on 2024-11-18, disclosed to the SEC on 2024-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.62 | 10,000 | $36K | 48.9% |
| 2 | $3.78 | 10,000 | $38K | 51.1% |
| Total | $3.70 avg | 20,000 | $74K | 100% |